{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:33:24Z","timestamp":1784194404779,"version":"3.55.0"},"reference-count":37,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T00:00:00Z","timestamp":1133827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Infections remain an important cause of morbidity and mortality in children with acute myeloid leukemia (AML), and particularly viridans group streptococci (VGS) sepsis. The present study, conducted between 1993 and 2003 in children with AML, sought to assess the frequency and characteristics of infectious complications (ICs), the incidence of VGS sepsis, the interest of preventive decontamination, and a possible cytarabine dose\u2010effect on the occurrence of ICs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Medical charts of 78 children treated according to the EORTC 58921 clinical trial were analyzed retrospectively. Patients were isolated in laminar air flow rooms, received non\u2010absorbable gut decontamination, gum decontamination with vancomycin mouthwash, and trimethoprim\u2010sulfamethoxasole. ICs were categorized as microbiologically documented infections (MDI), clinically documented infections (CDI), or fever of unknown origin (FUO).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 268 ICs occurred: 57.5% FUO, 8.5% CDI, and 34% MDI. Bloodstream infections occurred in 58 febrile episodes: Gram\u2010positive bacteria represented 83% of the pathogens including 66.1% Staphylococcus species and 8.5% Streptococcus species (6.8% VGS), Gram\u2010negative bacteria represented 13.5% of the pathogens and yeasts 3.5%. Five patients died of infection (6.4%). None died from bacterial infection and no case of VGS sepsis required intensive care. Invasive fungal infection was proven in four patients. Number of ICs was significantly different according to gum and gut decontamination status, and according to the cytarabine dose during the first intensification. No resistant strains were detected in spite of the use of local antibiotics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The low rate of VGS and enterobacteriaceae sepsis was probably due to the effective decontamination. Our supportive care strategy could potentially help enhance overall survival in children with AML. Pediatric Blood Cancer 2006;47:765\u2013772. \u00a9 2005 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.20706","type":"journal-article","created":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T21:47:28Z","timestamp":1133905648000},"page":"765-772","source":"Crossref","is-referenced-by-count":23,"title":["Low incidence of sepsis due to viridans streptococci in a ten\u2010year retrospective study of pediatric acute myeloid leukemia"],"prefix":"10.1002","volume":"47","author":[{"given":"A.S.","family":"Brunet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ploton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Galambrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pondarr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Pages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bleyzac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Freydi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Barb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,12,6]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199603)26:3<173::AID-MPO5>3.0.CO;2-H"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1182\/blood.V65.2.298.298","article-title":"Improved treatment results in childhood acute myelogenous leukemia: A report of the German cooperative study AML\u2010BFM\u201078","volume":"65","author":"Creutzig U","year":"1985","journal-title":"Blood"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.8.1448"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood.V87.12.4979.bloodjournal87124979","article-title":"Timed\u2010sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from Children's Cancer Group","volume":"87","author":"Woods WG","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1182\/blood.V75.10.1932.1932","article-title":"Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in the study AML\u2010BFM\u201083 as compared with study AML\u2010BFM\u201078","volume":"75","author":"Creutzig U","year":"1990","journal-title":"Blood"},{"key":"e_1_2_6_7_2","first-page":"18","article-title":"Idarubicin, high\u2010dose cytarabine, and etoposide for induction of remission in acute leukemia","volume":"33","author":"Mehta J","year":"1996","journal-title":"Semin Hematol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.1989.7.9.1260","article-title":"High\u2010dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: Long\u2010term follow\u2010up and results","volume":"7","author":"Wolf SN","year":"1989","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.4.572"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.10.2705"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401832"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403188"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200309000-00005"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.09.108"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.9.1845"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655400459513"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403932"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/323335"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01550.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199508000-00005"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198205000-00003"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402899"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.10320"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/598620"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10096-003-0894-6","article-title":"Prospective evaluation of the epidemiology, microbiology and outcome of bloodstream infections in hematologic patients in a single cancer center","volume":"22","author":"Velasco E","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.1.25"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701140"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000203976"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/345435"},{"key":"e_1_2_6_30_2","unstructured":"Barb\u00e9G SouilletG PlotonC et al.Reliability of controlled decontamination for preventing bacteremias in bone marrow transplantation: A ten\u2010year experience in a paediatric unit. Abstr. 43 9p. In abstract of the 7th European Congress of Clinical Microbiology and Infectious Diseases.1995 Vienna Austria."},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199505000-00009"},{"key":"e_1_2_6_32_2","first-page":"408","article-title":"Vancomycin\u2010resistant enterococci in pediatric hematology: No panic please!(in French)","volume":"46","author":"Barb\u00e9 G","year":"1998","journal-title":"Path Biol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.8.2492-2498.2003"},{"key":"e_1_2_6_34_2","unstructured":"MontecalvoMA HorowitzHV NadelmanR et al.Controlling IV Vancomycin on an oncology unit by infectious diseases consultation. Abstr N 15 p 138. ICAAC San Francisco 17\u201020\/09\/1995."},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.6.1201"},{"key":"e_1_2_6_36_2","first-page":"332a;","article-title":"Infectious complications of intensive chemotherapy on children's cancer group protocol CCG\u20102961 for pediatric acute myeloid leukemia","volume":"100","author":"Feusner JH","year":"2002","journal-title":"Blood"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0933-7407.2003.00931.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/339215"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.20706","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.20706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T10:59:11Z","timestamp":1696676351000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.20706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["10.1002\/pbc.20706"],"URL":"https:\/\/doi.org\/10.1002\/pbc.20706","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,6]]}}}